ChemicalBook >> CAS DataBase List >>N-[4-(2-methyl-4-oxopyrido[2,3-d]pyrimidin-3-yl)phenyl]-4-phenylbenzamide
N-[4-(2-methyl-4-oxopyrido[2,3-d]pyrimidin-3-yl)phenyl]-4-phenylbenzamide
- CAS No.
- 1005304-44-8
- Chemical Name:
- N-[4-(2-methyl-4-oxopyrido[2,3-d]pyrimidin-3-yl)phenyl]-4-phenylbenzamide
- Synonyms
- SARS-CoV-2 nsp13-IN-1;N-[4-(2-methyl-4-oxopyrido[2,3-d]pyrimidin-3-yl)phenyl]-4-phenylbenzamide;N-(4-(2-Methyl-4-oxopyrido[2,3-d]pyrimidin-3(4H)-yl)phenyl)-[1,1'-biphenyl]-4-carboxamide;N-(4-(2-Methyl-4-oxopyrido[2,3-d]pyrimidin-3(4H)-yl)phenyl)-[1,1'-biphenyl]-4-carboxamide;[1,1'-Biphenyl]-4-carboxamide, N-[4-(2-methyl-4-oxopyrido[2,3-d]pyrimidin-3(4H)-yl)phenyl]-
- CBNumber:
- CB03416051
- Molecular Formula:
- C27H20N4O2
- Molecular Weight:
- 432.47
- MDL Number:
- MOL File:
- 1005304-44-8.mol
- MSDS File:
- SDS
Last updated:2026-07-27 17:00:41
N-[4-(2-methyl-4-oxopyrido[2,3-d]pyrimidin-3-yl)phenyl]-4-phenylbenzamide price
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| ChemScene | CS-0534890 | SARS-CoV-2 nsp13-IN-1 99.91% | 1005304-44-8 | 5mg | $119 | 2026-06-04 | Buy |
| ChemScene | CS-0534890 | SARS-CoV-2 nsp13-IN-1 99.91% | 1005304-44-8 | 10mg | $195 | 2026-06-04 | Buy |
| ChemScene | CS-0534890 | SARS-CoV-2 nsp13-IN-1 99.91% | 1005304-44-8 | 25mg | $330 | 2026-06-04 | Buy |
| ChemScene | CS-0534890 | SARS-CoV-2 nsp13-IN-1 99.91% | 1005304-44-8 | 50mg | $493 | 2026-06-04 | Buy |
| ChemScene | CS-0534890 | SARS-CoV-2 nsp13-IN-1 99.91% | 1005304-44-8 | 100mg | $715 | 2026-06-04 | Buy |
N-[4-(2-methyl-4-oxopyrido[2,3-d]pyrimidin-3-yl)phenyl]-4-phenylbenzamide Chemical Properties, Uses, Production
Uses
SARS-CoV-2 nsp13-IN-1 (compound C1) is a potent nsp13 (non-structural protein 13) inhibitor. SARS-CoV-2 nsp13-IN-1 only inhibits nsp13 ssDNA+ ATPase, with an IC50 of 6 μM. SARS-CoV-2 nsp13-IN-1 does not inhibit ssDNA- ATPase. SARS-CoV-2 nsp13-IN-1 can be used for COVID-19 research[1].
References
[1] Yazdi AK, et al. Kinetic Characterization of SARS-CoV-2 nsp13 ATPase Activity and Discovery of Small-Molecule Inhibitors. ACS Infect Dis. 2022 Jul 13. DOI:10.1021/acsinfecdis.2c00165
N-[4-(2-methyl-4-oxopyrido[2,3-d]pyrimidin-3-yl)phenyl]-4-phenylbenzamide Preparation Products And Raw materials
Raw materials
Preparation Products
N-[4-(2-methyl-4-oxopyrido[2,3-d]pyrimidin-3-yl)phenyl]-4-phenylbenzamide Suppliers
Global Suppliers ( 8)
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Shanghai Beckham Medical Technology Co., Ltd | 13816613772 | huahero21@sina.com | China | 2994 | 55 |
| Tianjin Kailiqi Biotechnology Co., Ltd. | 15076683720 | klq@cw-bio.com | China | 9778 | 55 |
| TargetMol Chemicals Inc. | +1-781-999-5354; +1-00000000000 | marketing@targetmol.com | United States | 32431 | 58 |
| Jinan Jiuli Biotechnology Co. , Ltd. | 15865264761 | 486064515@qq.com | China | 5000 | 58 |
| Bide Pharmatech Ltd. | 400-1647117 13681763483 | product02@bidepharm.com | China | 59929 | 58 |
| Shanghai Yifei Biotechnology Co. , Ltd. | 021-65675885 18964387627 | customer_service@efebio.com | China | 11963 | 58 |
| TargetMol Chemicals Inc. | 15002134094 | marketing@targetmol.cn | China | 29874 | 58 |
| Guangzhou Ruidi Biotechnology Co., Ltd. | 020-82099279 18988941402 | sales@ubiochem.com | China | 9998 | 58 |
View Latest Price from N-[4-(2-methyl-4-oxopyrido[2,3-d]pyrimidin-3-yl)phenyl]-4-phenylbenzamide manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
![]() |
2026-08-08 | SARS-CoV-2 nsp13-IN-1
1005304-44-8
|
$53.00-148.00 | 99.77% | 10g | TargetMol Chemicals Inc. |
-

- SARS-CoV-2 nsp13-IN-1
1005304-44-8
- $53.00-148.00
- 99.77%
- TargetMol Chemicals Inc.
1005304-44-8 (N-[4-(2-methyl-4-oxopyrido[2,3-d]pyrimidin-3-yl)phenyl]-4-phenylbenzamide) Related Search:
N-[4-(2-methyl-4-oxopyrido[2,3-d]pyrimidin-3-yl)phenyl]-4-phenylbenzamide
Benzamide, N-[3-(2-methyl-4-oxopyrido[2,3-d]pyrimidin-3(4H)-yl)phenyl]-4-(trifluoromethyl)-
3-(3-Ethyl-4-oxo-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl)-propionic acid
4H-Dipyrrolo[1,2-a:2′,3′-d]pyrimidin-4-one, 1,6,7,8-tetrahydro-7,7-dimethyl-
3-(4-amino-3-fluorophenyl)-2-methylpyrido[2,3-d]pyrimidin-4-one
1of2
N-[4-(2-methyl-4-oxopyrido[2,3-d]pyrimidin-3-yl)phenyl]-4-phenylbenzamide
SARS-CoV-2 nsp13-IN-1
[1,1'-Biphenyl]-4-carboxamide, N-[4-(2-methyl-4-oxopyrido[2,3-d]pyrimidin-3(4H)-yl)phenyl]-
N-(4-(2-Methyl-4-oxopyrido[2,3-d]pyrimidin-3(4H)-yl)phenyl)-[1,1'-biphenyl]-4-carboxamide
N-(4-(2-Methyl-4-oxopyrido[2,3-d]pyrimidin-3(4H)-yl)phenyl)-[1,1'-biphenyl]-4-carboxamide
1005304-44-8




